Literature DB >> 2337959

Studies on the optimal immunization schedule of experimental animals. IV. The optimal age and sex of mice, and the influence of booster injections.

J G Hu1, T Yokoyama, T Kitagawa.   

Abstract

To establish the optimal condition for preparing mouse antiserum specific to a drug, the optimal age and sex of mice for the immune response were studied by measuring the mouse serum levels of total immunoglobulin G (IgG) and specific antibody to viomycin, as well as the changes in weight of mice immunized with a viomycin immunogen. It was observed that age was a more important factor than sex, and strongly affected productions of both total and specific IgGs of mice. The mice aged 8 weeks yielded the highest levels of both total IgG and the specific antibody. In the study on the influence of booster schedule, the number of boosters given had a larger influence on the immune response than the interval between priming and boosters. The greater the number of booster shots given, the less was the production of total and specific antibodies. The decrease in the weight of mice after immunization was also studied in more detail; it was found that it only occurred in the first week after priming but not after a booster injection. The mice aged eight weeks showed the largest weight loss.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2337959     DOI: 10.1248/cpb.38.448

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  2 in total

1.  Generation of High-Specificity Antibodies against Membrane Proteins Using DNA-Gold Micronanoplexes for Gene Gun Immunization.

Authors:  Debra T Hansen; Felicia M Craciunescu; Petra Fromme; Stephen A Johnston; Kathryn F Sykes
Journal:  Curr Protoc Protein Sci       Date:  2018-02-21

2.  Developing high-quality mouse monoclonal antibodies for neuroscience research - approaches, perspectives and opportunities.

Authors:  Belvin Gong; Karl D Murray; James S Trimmer
Journal:  N Biotechnol       Date:  2015-11-28       Impact factor: 5.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.